Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
As domestic manufacturers chug away at replenishing the nation's supply and the federal government imports baby formula from around the world, it's unclear what the nation's current inventory is. Here are four things to know about the shortage that's expected…
While backorders have always been a possibility with specific manufacturing issues, domestic and global factors have exacerbated the issue for healthcare systems across the U.S.
Here are 10 health systems that have posted job listings for supply chain expertise in the last week:
Citing the lack of childproof packaging, the U.S. Consumer Product Safety Commission recalled 407,050 units of four medications June 16.
Marlborough, Mass.-based Boston Scientific entered into a definitive agreement to shell out $230 million for Synergy's M.I. Tech, a medical device manufacturer and distributor, for a 64 percent stake by the end of 2022.
Forty-nine states have requested vaccines for children under 5 from the federal government. Florida is the only state that didn't sign up, according to the Miami Herald.
Less than two weeks after Abbott resumed producing infant formula at its Michigan plant, it's down again. This time, the problem is severe storm-induced flooding in parts of the factory, according to a June 15 press release.
The U.S. is running dry on more than 100 treatments, including cardiovascular, antibiotic and anti-infective drugs, according to the FDA.
Unlike recent national shortages of baby formula and contrast dye, there isn't data tracking the absence of tampons — but consumers are still struggling to find them.
As the nation awaits the recovery of the infant formula supply — which the FDA predicts will come at the end of July — a Rhode Island hospital initiated a human pasteurized milk program in May, according to CBS News.